These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9116176)

  • 21. Rationale for use of the Clinical Dementia Rating Sum of Boxes as a primary outcome measure for Alzheimer's disease clinical trials.
    Cedarbaum JM; Jaros M; Hernandez C; Coley N; Andrieu S; Grundman M; Vellas B;
    Alzheimers Dement; 2013 Feb; 9(1 Suppl):S45-55. PubMed ID: 22658286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of age on clinical and psychometric assessment of subjects with very mild or mild dementia of the Alzheimer type.
    Rubin EH; Storandt M; Miller JP; Grant EA; Kinscherf DA; Morris JC; Berg L
    Arch Neurol; 1993 Apr; 50(4):380-3. PubMed ID: 8460959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Target symptoms and outcome measures: cognition.
    Kirk A
    Can J Neurol Sci; 2007 Mar; 34 Suppl 1():S42-6. PubMed ID: 17469681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ADCS Prevention Instrument Project: behavioral measures in primary prevention trials.
    Cummings JL; Raman R; Ernstrom K; Salmon D; Ferris SH;
    Alzheimer Dis Assoc Disord; 2006; 20(4 Suppl 3):S147-51. PubMed ID: 17135808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Addenbrooke's cognitive examination III: diagnostic utility for mild cognitive impairment and dementia and correlation with standardized neuropsychological tests.
    Matias-Guiu JA; Cortés-Martínez A; Valles-Salgado M; Rognoni T; Fernández-Matarrubia M; Moreno-Ramos T; Matías-Guiu J
    Int Psychogeriatr; 2017 Jan; 29(1):105-113. PubMed ID: 27682860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential cognitive impairment in Alzheimer's disease and Huntington's disease.
    Brandt J; Folstein SE; Folstein MF
    Ann Neurol; 1988 Jun; 23(6):555-61. PubMed ID: 2970248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Screening for neuropsychological deficits--a screening test also for dementias?].
    Lang CJ; Balan P; Blunk J; Heckmann JG
    Nervenarzt; 2002 May; 73(5):434-41. PubMed ID: 12078021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening for Mild Cognitive Impairment Using the Dementia Rating Scale-2.
    Springate BA; Tremont G; Papandonatos G; Ott BR
    J Geriatr Psychiatry Neurol; 2014 Jun; 27(2):139-44. PubMed ID: 24578462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuropsychological assessment of severely demeted elderly: the severe cognitive impairment profile.
    Peavy GM; Salmon DP; Rice VA; Galasko D; Samuel W; Taylor KI; Ernesto C; Butters N; Thal L
    Arch Neurol; 1996 Apr; 53(4):367-72. PubMed ID: 8929160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropsychological assesment of psychogeriatric patients with limited education.
    Marcopulos BA; Gripshover DL; Broshek DK; McLain CA; Brashear HR
    Clin Neuropsychol; 1999 May; 13(2):147-56. PubMed ID: 10949156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rating scales for cognition in Huntington's disease: Critique and recommendations.
    Mestre TA; Bachoud-Lévi AC; Marinus J; Stout JC; Paulsen JS; Como P; Duff K; Sampaio C; Goetz CG; Cubo E; Stebbins GT; Martinez-Martin P;
    Mov Disord; 2018 Feb; 33(2):187-195. PubMed ID: 29278291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reliability and validity of a short form of the Severe Impairment Battery in Korean Alzheimer's disease patients.
    Ahn IS; Kim JH; Saxton J; Kim DK
    Int J Geriatr Psychiatry; 2007 Jul; 22(7):682-7. PubMed ID: 17160969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Global measures: utility in defining and measuring treatment response in dementia.
    Reisberg B
    Int Psychogeriatr; 2007 Jun; 19(3):421-56. PubMed ID: 17480241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal Neuropsychological Outcome in Taiwanese Alzheimer's Disease Patients Treated with Medication.
    Yang YH; Wu MN; Chou PS; Su HC; Lin SH; Sung PS
    Curr Alzheimer Res; 2018 Mar; 15(5):474-481. PubMed ID: 29032750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patterns of neuropsychological functioning among patients with multi-infarct and Alzheimer's dementia: a comparative analysis.
    Erker GJ; Searight HR; Peterson P
    Int Psychogeriatr; 1995; 7(3):393-406. PubMed ID: 8821347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alzheimer's disease can be accurately diagnosed in very mildly impaired individuals.
    Salmon DP; Thomas RG; Pay MM; Booth A; Hofstetter CR; Thal LJ; Katzman R
    Neurology; 2002 Oct; 59(7):1022-8. PubMed ID: 12370456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alzheimer's disease: correlational analysis of three screening tests and three behavioral scales.
    Villardita C; Lomeo C
    Acta Neurol Scand; 1992 Dec; 86(6):603-8. PubMed ID: 1481648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropsychological differentiation between Alzheimer's disease and dementia with Lewy bodies in a memory clinic.
    Kawai Y; Miura R; Tsujimoto M; Sakurai T; Yamaoka A; Takeda A; Arahata Y; Washimi Y; Kachi T; Toba K
    Psychogeriatrics; 2013 Sep; 13(3):157-63. PubMed ID: 25913764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive deficits of mild dementia: A comparison between dementia of the Alzheimer's type and vascular dementia.
    Matsuda O; Saito M; Sugishita M
    Psychiatry Clin Neurosci; 1998 Feb; 52(1):87-91. PubMed ID: 9682939
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.